Anti-VEGF-Antikörper

Patent europeic · EP2851372 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2851372
Numer da la dumonda
EP14191456
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-12-2008
Publitgà
25-03-2015
Concedì
01-02-2017
La protecziun finescha il pli tard
30-11-2028
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 16/00 (2006.01)
C07K 16/22 (2006.01)
C07K 16/32 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C12N 15/13 (2006.01)
Prioritad
US 991302 P 30.11.2007
Derivà da
EP08857287
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 09-03-2017

    Represchentant inscrit

    Representative
    F. HOFFMANN-LA ROCHE AG, Grenzacherstrasse 124, 4070 Basel

    Published in Swissreg on 09.03.2017

  6. 01-02-2017

    Concedì

    Published in Swissreg on 01.02.2017

Partidas

Possessur

GENENTECH, INC.

Genentech, Inc.

1 DNA Way, South San Francisco, CA 94080-4990, US

Represchentant

F. Hoffmann-La Roche AG

F. HOFFMANN-LA ROCHE AG

Grenzacherstrasse 124, 4070 Basel

Inventur

Fuh, Germaine

Pacifica, CA 94044, US

Lee, Chingwei, V.

Foster City, CA 94404, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.